A randomized controlled trial has met its primary endpoint in evaluating enVast-Assisted Mechanical Thrombectomy. The study focused on patients with large-thrombus STEMI. Results indicated a reduction in infarct size when compared to conventional PCI in these patients.

The findings were presented at the ESC Congress 2026 as Late-Breaking Science. This presentation suggests that the results are significant and worthy of attention.

Further details about the trial and its results can be found in the original source.